A method of preventing weakness in a patient with Parkinson's disease or of improving or restoring muscle strength of a patient with Parkinson's disease, comprising the step of administering to said patient an amount of one or more hepatocyte growth factor mimics sufficient to prevent, improve or restore to normal said muscle strength, said one or more hepatocyte growth factor mimics having a general structural formula 1 2 3 where R] is one of an N-acyl group, a substituted or unsubstiruted phenyl, a norleucine group, and an amino acid selected from tyrosine, phenylalanine, aspartic acid, arginine, isoleucine, serine, histidine, glycine, cysteine, methionine, tryptophan, lysine norvaline, ornithine, and s-benzyl cysteine
Common Questions (FAQ) Is peptide therapy safe
During the occurrence of DOR, the deterioration of mitochondrial function and the intensification of oxidative stress provide a platform for signaling crosstalk among various PCD forms (Seli et al., 2019)
And others never noticed at all because nobody taught them what to look for
Issues can arise if you lack histamine-degrading probiotics and have more histamine-producing strains
